Claes Martin

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy

Hans Lindå, Anders von Heijne, Eugene O. Major et al. · New England Journal of Medicine · 2009 · 217 citations · Full text

Diagnostic Virology, Autoimmune Disease, Immunology +11

T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis

Mohsen Khademi, Zsolt Illés, Alexander W. Gielen et al. · The Journal of Immunology · 2004 · 213 citations

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Joachim Burman, Ellen Iacobaeus, Anders Svenningsson et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 163 citations

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

Claes Martin, Malin Enbom, M. Söderström et al. · Acta Neurologica Scandinavica · 1997 · 105 citations